Post by Magnus Alsterlind

Welcome Natascha Boyko , Urs Limacher and the InnoMedicus team to our Swiss team in Asker Healthcare Group! Today, we are delighted to announce the acquisition of 100% of the shares in InnoMedicus AG, a highly respected niche distributor specializing in devices and solutions for precise diagnostics and minimally invasive therapies within urology, based in Switzerland. InnoMedicus has built a strong reputation for its expertise and commitment to innovation, particularly in the field of prostate cancer therapies. Their high-quality products, software solutions, and training have earned the trust of leading surgeons and urologists across Europe. We are honored that innoMedicus has chosen us as their partner for the next phase of their growth journey. Thank you to the InnoMedicus team for your professionalism and collaboration throughout this process. A special thank you to our dedicated team Cornel André Kägi ,Konrad Buza, Stefan Frey, Marc Willhalm and Michl Maier—for your great work in making this possible. Once again, a warm welcome and we are looking forward to the future and the opportunities we will create together!